Company: APXIF
Filing Date: 2025-01-22
Form Type: F-4
Source: 0001213900-25-005463
Chunk: 243

Company: APx Acquisition Corp. I
Filing Date: 2025-01-22
Form: F-4
Chunk 243
---
2 the 50% redemption of Public Shares, reflects the corresponding release of cash. For scenario 3 the 100% redemption of Public Shares, reflects corresponding release of cash for the entire amount held within the Trust Account. It also includes additional Company Shares issued to Theo I SCSp pursuant to the Backstop Agreement and assumes the obligations under the Backstop Agreement are satisfied through a cash contribution to OmnigenicsAI up to $10,000,000 in an amount that exceeds the aggregate amount of cash on deposit in the Trust Account (including any interest earned on the funds held in the Trust Account) remaining after payment in full of the SPAC Shareholder Redemption Amount, relative to each respective scenario, considering a price of $10 per share. See “ Certain Agreements Related to the Business Combination — Backstop Agreement.” Contributions performed under the Backstop Agreement were calculated as disclosed below: (a)Scenario 1: Considering that the balance in the Trust Account, including accrued interest receivable, is $6,034,687, the contribution under the Backstop Agreement amounts to $3,965,313. At a price of $10 per share, this contribution results in the issuance of 396,531shares. (b)Scenario 2:Considering that the balance in the Trust Account, including accrued interest receivable, is $3,017,344, the contribution under the Backstop Agreement amounts to $6,982,656. At a price of $10 per share, this contribution results in the issuance of 698,266shares. (c)Scenario 3: Considering that there is no balance in the Trust Account due to maximum redemptions, the contribution under the Backstop Agreement amounts to $10,000,000. At a price of $10 per share, this contribution results in the issuance of 1,000,000shares. The share capital reflects the exchange of the remaining shares according to each scenario explained above, for Company Shares, considering the par value of $0.0001 per share, as part of the Business Combination. Additionally, as described in section “ Business of APx and Certain Information About APx,” on December 8, 2023, APx held an extraordinary general meeting and its shareholders approved an amendment to the Existing Governing Documents and to the Trust Agreement to extend the Termination Date up to twelve (12) times for an additional one (1) month each time from December 9, 2023 to December 9, 2024, by deposit